Spots Global Cancer Trial Database for abraxane
Every month we try and update this database with for abraxane cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion (HAI) of Abraxane | NCT00732836 | Liver Cancer Advanced Cancer... Solid Tumors | HAI Abraxane Hepatic Artery ... IV Abraxane | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer | NCT00731380 | Head and Neck C... | ABI-007 | 18 Years - | University Health Network, Toronto | |
| The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer | NCT03647280 | Breast Cancer | Abraxane Epirubicin | 18 Years - 60 Years | Zhejiang Cancer Hospital | |
| A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | NCT02744898 | Endometrial Can... | Carboplatin AUC Abraxane | 18 Years - | NYU Langone Health | |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia | NCT02267707 | Pancreatic Neop... Cholestasis | nab-paclitaxel Gemcitabine | 18 Years - | Celgene | |
| Treatment of Pancreatic Cancer With Abraxane | NCT02555813 | Metastatic Panc... | Abraxane Gemcitabine | 18 Years - | Celgene | |
| A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors | NCT04731467 | Solid Tumor Non Small Cell ... Pancreatic Canc... Ovarian Cancer Papillary Thyro... Melanoma Colorectal Aden... | CM-24 and Nivol... CM-24, Nivoluma... CM-24, Nivoluma... Nivolumab, Nab ... Nivolumab and N... | 18 Years - | Purple Biotech Ltd. | |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | NCT01161186 | Pancreatic Neop... Pancreatic Canc... Adenocarcinoma | nab-paclitaxel,... | 18 Years - | University of California, San Francisco | |
| Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) | NCT01416558 | Metastatic Brea... | Nab-Paclitaxel | 18 Years - | German Breast Group | |
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC | NCT03665441 | Pancreatic Aden... | eryaspase Gemcitabine plu... Irinotecan plus... | 18 Years - | ERYtech Pharma | |
| Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer | NCT00503906 | Breast Cancer | Avastin Gemcitabine Abraxane | 18 Years - 120 Years | University of Miami | |
| Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | NCT01298011 | Resectable Panc... | Gemcitabine and... | 18 Years - | Pancreatic Cancer Research Team | |
| Treatment With Nab-paclitaxel in Cutaneous SCC | NCT02076243 | Cutaneous Squam... | nab-paclitaxel | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer | NCT01506973 | Advanced Adenoc... Metastatic Aden... | Hydroxychloroqu... Gemcitabine Abraxane | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer | NCT01938833 | HER2-negative B... Inflammatory Br... Male Breast Can... Recurrent Breas... Stage IV Breast... | Romidepsin Abraxane | 18 Years - | Thomas Jefferson University | |
| Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer | NCT01647672 | Breast Cancer | Abraxane | - | Tianjin Medical University | |
| Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | NCT00394251 | Breast Cancer | Adriamycin and ... ABI-007 Taxol Bevacizumab pegfilgrastim | 18 Years - 70 Years | Celgene | |
| Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma | NCT01933061 | Metastatic Mela... | Abraxane Abraxane | 18 Years - | Celgene | |
| Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer | NCT04670978 | Objective Respo... | albumin-bound p... | 18 Years - 70 Years | Shandong University | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | NCT00308178 | Breast Cancer | Abraxane | 18 Years - | Dana-Farber Cancer Institute | |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane | NCT03003078 | Unresectable Lo... | OncoSil™ | 18 Years - | OncoSil Medical Limited | |
| Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | NCT00521781 | Prostatic Neopl... | Abraxane Leuprolide Bicalutamide | 18 Years - | The Methodist Hospital Research Institute | |
| Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy | NCT02303977 | Patients With S... | Abraxane Gemcitabine | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer | NCT02250326 | Carcinoma, Non-... | nab-paclitaxel ... CC-486 Duravalumab | 18 Years - | Celgene | |
| Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer | NCT01715142 | Pancreatic Aden... Pancreatic Aden... Pancreatic Aden... | Gemcitabine Abraxane | 18 Years - | Erasme University Hospital | |
| A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma | NCT00864253 | Malignant Melan... | ABI-007 Dacarbazine | 18 Years - | Celgene | |
| Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) | NCT00625573 | Colorectal Canc... | Abraxane | 18 Years - 90 Years | Mt. Sinai Medical Center, Miami | |
| A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors | NCT01733004 | Hepatocellular ... | MM-141 | 18 Years - | Merrimack Pharmaceuticals | |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | NCT02707328 | Pancreas Cancer Pancreatic Canc... Adenocarcinoma ... Pancreas Adenoc... Pancreatic Aden... | Gemcitabine nab-paclitaxel CyberKnife | 18 Years - | The Cooper Health System | |
| Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas | NCT01730586 | Colorectal Canc... Cancer of Gastr... | Abraxane | 18 Years - | M.D. Anderson Cancer Center | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer | NCT04590625 | Ovarian Cancer | Apatinib Mesyla... Abraxane Cis Platinum Carboplatin | 18 Years - 75 Years | Zhongshan Hospital Xiamen University | |
| Abraxane and Alimta in Advanced Solid Tumors | NCT00470548 | Breast Cancer Lung Cancer Unspecified Adu... | Abraxane Alimta | 18 Years - | University of California, Davis | |
| Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer | NCT02027428 | Squamous Cell C... | Abraxane (Induc... Carboplatin (In... Abraxane (Maint... Best Supportive... Abraxane (Induc... Carboplatin (In... Best Supportive... | 18 Years - | Celgene | |
| Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | NCT00736944 | Squamous Cell C... | Abraxane Cetuximab Cetuximab Cisplatin 5-FU Radiation (Post... Cisplatin Cetuximab | 18 Years - | Washington University School of Medicine | |
| A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer | NCT02670746 | Pancreatic Neop... | 18 Years - | Celgene | ||
| Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer | NCT02752685 | Breast Cancer | Pembrolizumab Nab-Paclitaxel | 18 Years - | NYU Langone Health | |
| Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers | NCT00473720 | Advanced Cancer... | Satraplatin Abraxane | 18 Years - | Yale University | |
| A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma | NCT01839799 | Pancreatic Aden... | Gemcitabine Abraxane FOLFIRINOX Chemoradiation | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel | NCT01192165 | Cancer | Trametinib (GSK... Docetaxel Erlotinib Pemetrexed Carboplatin nab-Paclitaxel Cisplatin | 18 Years - | GlaxoSmithKline | |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01412229 | Head and Neck C... | Cetuximab Nab-paclitaxel Carboplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer | NCT03950570 | Advanced Solid ... Metastatic Brea... | Abraxane | 18 Years - | Orinove, Inc. | |
| Non-interventional Study With Nab-Paclitaxel (Abraxane®) | NCT01689610 | Metastatic Brea... | 18 Years - | iOMEDICO AG | ||
| A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors | NCT04731467 | Solid Tumor Non Small Cell ... Pancreatic Canc... Ovarian Cancer Papillary Thyro... Melanoma Colorectal Aden... | CM-24 and Nivol... CM-24, Nivoluma... CM-24, Nivoluma... Nivolumab, Nab ... Nivolumab and N... | 18 Years - | Purple Biotech Ltd. | |
| PT886 For Treatment of Patients With Metastatic/Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinoma (the TWINPEAK Study) | NCT05482893 | Gastric or Gast... Pancreatic Duct... | PT886 Paclitaxel Gemcitabine Abraxane KEYTRUDA® (pemb... Oxaliplatin Leucovorin Fluorouracil Capecitabine | 18 Years - | Phanes Therapeutics | |
| Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer | NCT00642759 | Non-small Cell ... | carboplatin Nab-paclitaxel Bevacizumab | 18 Years - | Massachusetts General Hospital | |
| Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | NCT02024009 | Pancreatic Neop... | nab-paclitaxel 60Gy in 30# 50.4Gy in 28# Nelfinavir Capecitabine Gemcitabine | 18 Years - | University of Oxford | |
| Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | NCT00107094 | Breast Cancer | Abraxane | 18 Years - 70 Years | Celgene Corporation | |
| Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | NCT02769832 | Small Cell Lung... | Nab-paclitaxel Gemcitabine | 18 Years - 99 Years | University of Iowa | |
| Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab | NCT00319839 | Head and Neck C... | Abraxane Cetuximab | 18 Years - | University of California, Irvine | |
| Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates | NCT02723331 | Pancreatic Canc... Pancreatic Aden... Pancreas Ductal... | Nab paclitaxel Gemcitabine | 18 Years - 101 Years | University of Colorado, Denver | |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | NCT02581501 | Pancreatic Canc... | GAX - Gemcitabi... | 18 Years - | Stamford Hospital | |
| Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice | NCT02655159 | Breast Neoplasm... | 18 Years - | Celgene Corporation | ||
| Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | NCT01693276 | Pancreatic Canc... | Gemcitabine Abraxane Radiation Thera... | 18 Years - | University of Cincinnati | |
| Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | NCT02581501 | Pancreatic Canc... | GAX - Gemcitabi... | 18 Years - | Stamford Hospital | |
| A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer | NCT02662634 | Non-small Cell ... | AGS-003-LNG Carboplatin Abraxane Alimta Cisplatin Taxol Radiation Thera... | 19 Years - | GU Research Network, LLC | |
| Hepatic Arterial Infusion (HAI) of Abraxane | NCT00732836 | Liver Cancer Advanced Cancer... Solid Tumors | HAI Abraxane Hepatic Artery ... IV Abraxane | 18 Years - | M.D. Anderson Cancer Center | |
| Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | NCT00193206 | Breast Cancer | Gemcitabine Epirubicin Albumin-bound P... | 18 Years - | SCRI Development Innovations, LLC | |
| Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer | NCT00723125 | Breast Cancer | Abraxane Carboplatin Avastin | 18 Years - | Brown University | |
| Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) | NCT02124369 | Pancreatic Aden... | Abraxane Gemcitabine | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer | NCT03950570 | Advanced Solid ... Metastatic Brea... | Abraxane | 18 Years - | Orinove, Inc. | |
| A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer | NCT02207465 | Locally Advance... Borderline Rese... | Radiotherapy Abraxane | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma | NCT00970996 | Melanoma | Temozolomide Abraxane Cisplatin Interleukin-2 Interferon alph... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma | NCT01555853 | Lymphoma, Non-H... Hodgkin Disease | Abraxane | 18 Years - | Washington University School of Medicine | |
| Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma | NCT01827111 | Melanoma | ABI-007 Ipilimumab Phone Call | 12 Years - 70 Years | M.D. Anderson Cancer Center | |
| Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | NCT00193206 | Breast Cancer | Gemcitabine Epirubicin Albumin-bound P... | 18 Years - | SCRI Development Innovations, LLC | |
| Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver | NCT00833807 | Melanoma Liver Metastasi... | Nab-Paclitaxel ... | 18 Years - | M.D. Anderson Cancer Center | |
| Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany) | NCT01416558 | Metastatic Brea... | Nab-Paclitaxel | 18 Years - | German Breast Group | |
| Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | NCT00284752 | Prostate Cancer | Abraxane | 18 Years - | Kaiser Permanente | |
| Treatment of Pancreatic Cancer With Abraxane | NCT02555813 | Metastatic Panc... | Abraxane Gemcitabine | 18 Years - | Celgene | |
| A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors | NCT01733004 | Hepatocellular ... | MM-141 | 18 Years - | Merrimack Pharmaceuticals | |
| ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer | NCT03950570 | Advanced Solid ... Metastatic Brea... | Abraxane | 18 Years - | Orinove, Inc. | |
| A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers | NCT00337376 | Advanced Solid ... | Rapamune Abraxane | 18 Years - | Yale University | |
| Study of Trametinib and Nab-paclitaxel in Patients With Melanoma | NCT02300935 | Melanoma | trametinib nab-paclitaxel | 18 Years - | SCRI Development Innovations, LLC | |
| Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) | NCT02301143 | Pancreatic Neop... | nab-Paclitaxel Gemcitabine Chemoradiation Capecitabine Surgery | 18 Years - | Celgene | |
| Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer. | NCT03252808 | Pancreatic Canc... Pancreatic Canc... | TBI-1401(HF10) Gemcitabine Nab-paclitaxel TS-1 | 20 Years - | Takara Bio Inc. | |
| A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer | NCT00731380 | Head and Neck C... | ABI-007 | 18 Years - | University Health Network, Toronto | |
| Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer | NCT00723125 | Breast Cancer | Abraxane Carboplatin Avastin | 18 Years - | Brown University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
